Empty Hepatitis E virus shells used to carry vaccines
4 February 2016 | By Victoria White
Researchers showed that virus-like particles carrying LXY-30 could home in on breast cancer cells both in a laboratory dish and in a mouse model...
List view / Grid view
News
Selvita opens new research site in Poland
4 February 2016 | By Victoria White
The new site will be located at in the Wielkopolska Centre of Advanced Technologies, Poznan, and commence research activities in the summer of 2016...
Mersana and Takeda expand partnership to advance XMT-1522
3 February 2016 | By Victoria White
XMT-1522 is an investigational, Fleximer-based ADC therapy that targets HER2-expressing tumours, including breast, gastric and non-small cell lung cancers...
London Cancer Hub to accelerate the discovery of treatments
3 February 2016 | By Victoria White
A new ‘roadmap’ document published today outlines how The London Cancer Hub will become a world-leading life-science campus...
Teva and AbCellera team up to discover monoclonal antibodies
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
Adaptimmune and GSK expand cancer immunotherapy collaboration
3 February 2016 | By Victoria White
The enhanced agreement will accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell immunotherapy targeting NY-ESO-1...
Leicester’s Dr Echalier awarded Domainex’s Discovery STAR AWARD
3 February 2016 | By Victoria White
This award will give Dr Echalier access to the drug discovery capabilities of Domainex in support of her research...
MISSION Therapeutics raises £60m to advance DUB inhibitors
2 February 2016 | By Victoria White
The £60 million enables the company to maximise the potential of its DUB platform and advance a series of DUB inhibitors...
Non-coding RNA helps suppress breast cancer
2 February 2016 | By Victoria White
A team of scientists from Bath, Cambridge and the USA has identified a piece of non-coding RNA that stops cells turning cancerous...
Cell Therapy Catapult becomes Cell and Gene Therapy Catapult
2 February 2016 | By Victoria White
The Cell Therapy Catapult has changed its name to the Cell and Gene Therapy Catapult to more accurately reflect the activities of the organisation...
HFEA approves embryo gene editing
1 February 2016 | By Victoria White
The aim of the research is to understand the genes human embryos need to develop successfully...
Stem cells that can repair the skull and face bones
1 February 2016 | By Victoria White
Scientists have, for the first time, identified and isolated stem cells capable of skull formation and craniofacial bone repair in mice...
Astellas and CLINO team up for retinitis pigmentosa gene therapy
1 February 2016 | By Victoria White
Astellas and CLINO have entered into a license agreement for the worldwide development and commercialisation of Adeno-associated Virus-modified Volvox channelrhodopsin-1 (AAV-mVChR1)...
Nordic Nanovector awarded grant to develop novel therapeutics
1 February 2016 | By Victoria White
Nordic Nanovector has been awarded the NOK 15 million grant from the Research Council of Norway’s User-driven Research-based Innovation programme...
Epigenome mining leads to medulloblastoma discovery
29 January 2016 | By Victoria White
Researchers have identified the cells that likely give rise to the brain tumour subtype Group 4 medulloblastoma, removing a barrier to developing more effective targeted therapies....
